Picture of Shield Therapeutics logo

STX — Shield Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Shield Therapeutics Announces Positive Results In Pediatric Trial

Oct 1 (Reuters) - Shield Therapeutics PLC STXS.L:

SHIELD THERAPEUTICS  - POSITIVE EFFICACY AND TOLERANCE IN PEDIATRIC TRIAL

SHIELD THERAPEUTICS PLC - SIGNIFICANT HB IMPROVEMENTS OBSERVED IN TRIAL GROUPS

SHIELD THERAPEUTICS PLC - NO DISCONTINUATIONS IN FERRIC MALTOL GROUP DUE TO ADVERSE EVENTS

SHIELD THERAPEUTICS PLC - NO SERIOUS ADVERSE EVENTS REPORTED IN TRIAL GROUPS

Source text: ID:nRSA5065Ba

Further company coverage: STXS.L

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shield Therapeutics

See all news